← Open Payments lookup

ADDIEVI AMPER: Open Payments

NPI 1346671401 · MISSION, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$586 in 5 payments from 5 companies in 2025. Trend: 2023 $381 · 2024 $974 · 2025 $586

Food & beverage: $586
CompanyPaymentsAmount
Melinta Therapeutics, LLC1$125
Alkermes, Inc.1$125
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$125
Otsuka America Pharmaceutical, Inc.1$124
Lilly USA, LLC1$88

Products named: Rezzayo, ARISTADA, CAPLYTA, REXULTI.

Industry payments across TX — which companies pay providers there.